Literature DB >> 9449649

Androgens accelerate thymocyte apoptosis.

N J Olsen1, S M Viselli, J Fan, W J Kovacs.   

Abstract

Mechanisms of androgen-induced thymic involution are largely undefined. We have found that significant decreases in thymic size occur 2-4 h after a dose of testosterone is administered to castrated male mice. This rapid rate of change suggests a role for androgen-induced apoptosis in modulating the size and composition of the thymus. Using thymic organ cultures to define these effects of androgens, we found that dihydrotestosterone treatment of thymus tissues from females or from castrated males results in enhancement of thymocyte apoptosis. Intact (androgen-replete) or testicular feminization, Tfm/Y (androgen-resistant) mice failed to show apoptotic change with androgen treatment, although the apoptotic response to glucocorticoids was present, suggesting a requirement for a functional androgen receptor. Acceleration of thymocyte apoptosis by androgens may mediate processes of thymocyte selection, with the potential to impart gender-specific characteristics on the peripheral T cell repertoire.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449649     DOI: 10.1210/endo.139.2.5729

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  38 in total

Review 1.  Gender dimorphism in immune responses following trauma and hemorrhage.

Authors:  Yukihiro Yokoyama; Martin G Schwacha; T S Anantha Samy; Kirby I Bland; Irshad H Chaudry
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies.

Authors:  Wee J Chng; Guat B Tan; Ponnudurai Kuperan
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

Review 3.  Effects of androgens on T and B lymphocyte development.

Authors:  N J Olsen; W J Kovacs
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 4.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 5.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

6.  CCL25 increases thymopoiesis after androgen withdrawal.

Authors:  Kirsten M Williams; Philip J Lucas; Catherine V Bare; Jiun Wang; Yu-Waye Chu; Ezekiel Tayler; Veena Kapoor; Ronald E Gress
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

7.  Reference ranges for lymphocyte subsets among healthy Hong Kong Chinese adults by single-platform flow cytometry.

Authors:  W S Wong; A W I Lo; L P Siu; J N S Leung; S P Tu; S W Tai; S C Lam; K F Wong
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

Review 8.  Thymic stromal cells: Roles in atrophy and age-associated dysfunction of the thymus.

Authors:  Sergio Cepeda; Ann V Griffith
Journal:  Exp Gerontol       Date:  2017-12-24       Impact factor: 4.032

9.  Peripheral blood lymphocyte subsets in adolescents: a longitudinal analysis from the REACH project.

Authors:  Bret J Rudy; Craig M Wilson; Stephen Durako; Anna-Barbara Moscicki; Larry Muenz; Steven D Douglas
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development.

Authors:  Amin Al-Shami; Kanchan G Jhaver; Peter Vogel; Carrie Wilkins; Juliane Humphries; John J Davis; Nianhua Xu; David G Potter; Brenda Gerhardt; Robert Mullinax; Cynthia R Shirley; Stephen J Anderson; Tamas Oravecz
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.